Baxter International Inc. fell$. 12 or. 2 percent, to $68.02. Boston Scientific Corp. fell$. 08 or. 5 percent, to $17.44. Johnson& Johnson fell$. 20 or. 2 percent, to $100.14.» Read More
In recent years, as the surgical robot's popularity has grown, so have questions and concerns about its safety, training and the aggressiveness of its marketing.
A sharp and surprisingly persistent slowdown in the growth of health care costs is helping to narrow the federal deficit, leaving budget experts trying to figure out whether the trend will last.
An internal analysis conducted by Johnson & Johnson in 2011 estimated that the all-metal device would fail within five years in nearly 40 percent of patients who received it, newly disclosed court records show.
DaVita could be a beneficiary among health care stocks from changes in the U.S. health care market, an analyst said Wednesday.
It was a complicated case, in part because the reform legislation itself was seriously flawed. The law’s drafters could have proposed a simpler and more efficient system, the New York Times reports.
While some people are frustrated about the long wait times for doctors appointments, some believe doctors are doing their jobs.
American spends more on health care than any other country. Do you know where it goes?
Over the last 20 years, Americans have witnessed unprecedented advances in care of hospitalized patients. Improved diagnostic procedures, quantum leaps in medical technology, enhanced treatments and a public now familiar with the concept of preventative medical care all mean that healthcare – especially in the hospital – has changed to meet the health care needs of today’s patients.
With stocks shrugging off the wall of worry in the first quarter, the second quarter could prove to be a less rewarding time for those long equity markets as central banks begin to tighten policy via rate hikes or withdrawing extraordinary measures.
The "Mad Money" host shares a few interesting spec plays in the health care space.